Earnings Feed
Start Free
GeneDx Holdings Corp.·4

Jun 23, 4:30 PM ET

RUCH JOSHUA 4

Research Summary

AI-generated summary

Updated

GeneDx (WGS) Director Joshua Ruch Receives RSUs, Converts Derivatives

What Happened

  • Joshua Ruch, a director of GeneDx Holdings Corp. (WGS), was granted 4,248 restricted stock units (RSUs) on 2026-06-18 (reported on a Form 4 filed 2026-06-23). On the same date he also recorded conversion/exercise transactions of 3,576 derivative units that were both acquired and disposed on 2026-06-18. All transactions are reported with a $0.00 per-share price, yielding $0 reported cash value.
  • The grant (code A) is an award of RSUs; the M-code entries are conversion/exercise of derivatives. The same-day acquire-and-dispose of 3,576 shares indicates conversion/settlement activity rather than a standard open-market purchase.

Key Details

  • Transaction dates: 2026-06-18 (transactions); Form 4 filed 2026-06-23 (appears filed ~5 days after the transaction and later than the usual 2-business-day Form 4 deadline).
  • Reported amounts/prices: 4,248 RSUs granted @ $0.00; 3,576 derivative units converted/acquired @ $0.00 and 3,576 derivative units converted/disposed @ $0.00.
  • Shares owned after transaction: not specified in the provided filing data.
  • Relevant footnotes:
    • F1: Each RSU represents a contingent right to receive 1 share upon settlement for no consideration.
    • F3/F4: Vesting schedules — the new RSU award vests on the earlier of the 2027 annual meeting or first anniversary (F3); the earlier award/units vested or vest on the earlier of the 2026 annual meeting or first anniversary (F4).
    • F2: Reporting person is managing member of certain entities (Kariba, RUGU2, Q9) and disclaims beneficial ownership of securities held by those entities except to the extent of any pecuniary interest.
  • Filing timeliness: filed 2026-06-23 for 2026-06-18 transactions; appears late relative to the standard 2-business-day Form 4 filing requirement.

Context

  • RSUs are awards that convert into shares upon settlement (per F1) and are commonly used as compensation; they are acquisitions (not open-market purchases) and do not necessarily signal a personal cash investment by the insider.
  • The M-code conversions recorded at $0 likely reflect conversion/settlement of derivative awards (or transfers related to settlement/withholding), not a cash purchase or reported cash sale — the filing does not specify the reason for the same-day disposition.